CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
research
Improved early detection of ovarian cancer using longitudinal multimarker models
Authors
Oleg Blyuss
Aleksandra Gentry-Maharaj
+9 more
Richard Gunu
Ian Jacobs
Jatinderpal Kalsi
Usha Menon
Andy Ryan
John F. Timms
Harry J. Whitwell
Jenny Worthington
Alexey Zaikin
Publication date
16 December 2019
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.Background: Ovarian cancer has a poor survival rate due to late diagnosis and improved methods are needed for its early detection. Our primary objective was to identify and incorporate additional biomarkers into longitudinal models to improve on the performance of CA125 as a first-line screening test for ovarian cancer. Methods: This case–control study nested within UKCTOCS used 490 serial serum samples from 49 women later diagnosed with ovarian cancer and 31 control women who were cancer-free. Proteomics-based biomarker discovery was carried out using pooled samples and selected candidates, including those from the literature, assayed in all serial samples. Multimarker longitudinal models were derived and tested against CA125 for early detection of ovarian cancer. Results: The best performing models, incorporating CA125, HE4, CHI3L1, PEBP4 and/or AGR2, provided 85.7% sensitivity at 95.4% specificity up to 1 year before diagnosis, significantly improving on CA125 alone. For Type II cases (mostly high-grade serous), models achieved 95.5% sensitivity at 95.4% specificity. Predictive values were elevated earlier than CA125, showing the potential of models to improve lead time. Conclusions: We have identified candidate biomarkers and tested longitudinal multimarker models that significantly improve on CA125 for early detection of ovarian cancer. These models now warrant independent validation.Peer reviewe
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
University of Hertfordshire Research Archive
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:uhra.herts.ac.uk:2299/2216...
Last time updated on 09/03/2020
Supporting member
Spiral - Imperial College Digital Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:spiral.imperial.ac.uk:1004...
Last time updated on 15/09/2021
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 20/04/2021
UCL Discovery
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:eprints.ucl.ac.uk.OAI2:100...
Last time updated on 26/05/2020